Medtronic plc income statement & cash flow
In the fiscal year ended Apr 24, 2026, Medtronic plc reported net income of $4.80B on revenue of $36.36B. Operating cash flow was $7.33B and capital expenditures were $1.90B, leaving $5.43B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.71B | $29.95B | $30.56B | $28.91B | $30.12B | $31.69B | $31.23B | $32.36B | $33.54B | $36.36B |
| Gross profit | $20.42B | $20.90B | — | — | — | — | — | — | — | — |
| Operating income | $5.38B | $6.64B | $6.27B | $4.79B | $4.48B | $5.75B | $5.49B | $5.14B | $5.96B | $6.47B |
| Net income | $4.03B | $3.10B | $4.63B | $4.79B | $3.61B | $5.04B | $3.76B | $3.68B | $4.66B | $4.80B |
| Diluted EPS | $2.89 | $2.27 | $3.41 | $3.54 | $2.66 | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 |
| Operating cash flow | $6.88B | $4.68B | $7.01B | $7.23B | $6.24B | $7.35B | $6.04B | $6.79B | $7.04B | $7.33B |
| Capital expenditures | $1.25B | $1.07B | $1.13B | $1.21B | $1.35B | $1.37B | $1.46B | $1.59B | $1.86B | $1.90B |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Apr 2026 | — | 17.8% | 13.2% |
| Apr 2025 | — | 17.8% | 13.9% |
| Apr 2024 | — | 15.9% | 11.4% |
| Apr 2023 | — | 17.6% | 12.0% |
| Apr 2022 | — | 18.2% | 15.9% |
Source: SEC EDGAR XBRL company facts for CIK 1613103 (raw data). Most recent filing in this dataset: 10-Q filed Sep 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.